CJC-1295 No DAC 5mg/10mg Research Peptide
GHRH Analog · Pulsatile GH Research · COA Verified
For research and laboratory use only. Not for human consumption. By purchasing, you confirm you are a qualified researcher.
Product Details
For Research Purposes Only. Not approved for human consumption.
CJC-1295 No DAC Research Peptide 10mg
CJC-1295 without DAC (Modified GRF 1-29) is a synthetic analog of the first 29 amino acids of endogenous GHRH. With a half-life of ~30 minutes it produces pulsatile GH release mimicking natural GH secretion rhythms — making it the preferred GHRH analog for physiologically accurate GH pulse research. Frequently combined with Ipamorelin for synergistic dual-pathway GH secretagogue studies.
Research Applications
Pulsatile GH secretion pattern research
Hypothalamic-pituitary axis studies
IGF-1 regulation investigations
Combination GHRH + GHRP protocols
Body composition and metabolic research
Quality Specifications
Purity: ≥98% (HPLC verified)
Compound: CJC-1295 (No DAC)
Molecular Weight: 3367.9 Da
Form: Lyophilized powder
Origin: Made in the USA
Testing: Third-party tested in a US laboratory
Storage: -20°C, protect from light
COA: Batch-specific, ISO-accredited laboratory
Frequently Asked Questions
Q: DAC vs. No DAC — which do I choose?A: No DAC (30 min half-life) mimics natural pulsatile GH physiology. DAC (6-8 day half-life) produces sustained, continuous GH stimulation. Choose based on your research design.
Q: Why combine with Ipamorelin?A: CJC-1295 No DAC targets GHRH receptors; Ipamorelin targets ghrelin receptors. Two independent pathways produce synergistic GH release.
Q: What downstream effects does GHRH activation produce?A: Pituitary GH release → hepatic IGF-1 production → effects on protein synthesis, fat metabolism, and cellular regeneration across multiple tissues.
Related Research: Ipamorelin | CJC-1295 DAC | Sermorelin | Hexarelin Research Peptide
For laboratory research use only. Not for human consumption. Not evaluated by the FDA.